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PROTEOMICS AS A TOOL FOR STUDYING OSTEOARTHRITIS
D. de Seny. GIGA Res., Univ. of Liège, CHU Liège, Liège, Belgium
Proteomics is the large-scale study of proteins expressed by cells,
tissues or organ. It describes the dynamics of cell regulation by
detecting molecular events related to the development of a disease. It is
a multidisciplinary approach using medical, biological, bioanalytical
and bioinformatics knowledge. One of the most promising applications
of proteomics studies is identiﬁcation of new biomarkers as indicators
of pathogenic processes or pharmacologic responses to a therapeutic
intervention. However, several practical considerations need to be
raised to set up a robust and sensitive strategy for biomarker discovery
in osteoarthritis (OA). OA is a heterogeneous, complex joint pathology.
Progression of OA is slow and periodic with intermittent episodes of
inﬂammatory ﬂares and remission periods. Therefore, biomarkers are
discontinuously released in biological ﬂuids.
This presentation will focus on current proteomic approaches and their
limitations in identifying the so-called soluble or “wet biomarkers”
measured in blood, serum, plasma, urine and synovial ﬂuid. The pres-
ence of a high quantity of proteins in such complex biological ﬂuid
make biomarkers discovery highly challenging. Nevertheless, current
approaches exist to extend accessible concentration range and deep
proteome detection. Comparison between a “targeted proteomic
approach” based in the evaluation of single disease-related molecule
levels and a “non-targeted proteomic approach” based on the simul-
taneous evaluation of hundreds proteins in a blind experiment using
gel-based methods or mass spectrometry will be reviewed. Based on
the assumption that a combination of biomarkers is more speciﬁc and
sensitive for disease diagnosis than single marker, non-targeted pro-
teomic technologies became highly attractive over the last decade.
However, the gap between biomarkers discovery and clinical imple-
mentation remains important, as only few biomarkers have already
been validated. All these practical considerations will be illustrated by
current proteomics studies.
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REHABILITATION FOR CARTILAGE DEFECT IN EARLY KNEE OA
M. Risberg. NAR, Dept. of Sport Med., Norwegian Sch. Sport Sci., Oslo,
Norway
Background: It is well established that treatment and rehabilitation of
patients with knee OA needs to start early in the disease process. Knee
injuries and obesity have shown to be two of the most signiﬁcant
predictors for onset and progression of knee OA largely mediated by
biomechanical forces acting across the knee. Articular cartilage in the
knee is prone to damage by trauma or degeneration and damaged
cartilage is one of the key issues in the OAdisease process. Focal cartilage
defects as well as other major knee injuries affect the mechanical envi-
ronment in the joint possibly through changes in knee articular cartilage
loading. The effect of exercise interventions for reducing symptoms and
improving function in patients with knee OA has been well established,
but the effect of exercise therapy for patients with focal cartilage defects
is spares. Cartilage loading has shown to be signiﬁcant for cartilage
health, however, we lack knowledge on how muscle function affect
cartilage health. Quadriceps muscle strength in particular has shown to
inﬂuence load transmission and absorption across the knee joint
Objective: The objective of this presentation is to go through the
evidence for the effect of exercises for patients with cartilage defect in
early knee OA. Furthermore, the aim is to present the Oslo CARE study
to highlight the need for speciﬁcally descried exercise therapy programs
and how this exercise therapy program have shown to inﬂuence
symptoms, disabilities and cartilage quality using quantitative MRI.
Methods: A narrative literature review will be presented as well as the
development of the exercise therapy program and the outcomes from
the Oslo CARE study. The Oslo CARE study included balance exercises,
balance with resistance, followed by traditionally resistance training
and ﬁnally plyometric exercises for patients with focal cartilage defects.
The exercises aimed at generating muscle strength and power impor-
tant for daily life and sport performance, without a potential deleterious
effect on cartilage health.Results: Clinically patients with focal cartilage defect experience pain,
effusion, muscle weakness and other neuromuscular deﬁcits.
Furthermore, there is a wide range of the type, size and location of the
patients’ focal cartilage defect that should inﬂuence the type of
exercises performed. It has been stated that conservative management
of patients with cartilage defect are inappropriate since they are likely
non-responders to such treatment. There are to our knowledge no
RCTs on the effect of exercise therapy for patients with focal cartilage
defects, but a few studies have examined the effect of exercises after
cartilage repair. Different theories have been proposed for why exer-
cises seem to work for patients with knee OA: neuromuscular, peri-
articular, intra-articular components, general ﬁtness/health, and
psychosocial. Studies seem to support that at least low to moderate
activities and exercises improve function and are not deleterious to
the knee articular cartilage. However, the mechanisms for why exer-
cises seem to affect the patients' symptoms or function are not well
understood. The Oslo CARE study showed that patients with focal
cartilage defects improved knee function over time, without delete-
rious on the knee articular cartilage.
Discussion: We need to increase our focus on why exercises seem to
work for patients with cartilage defects in early knee OA. We need to
move from the palliative treatment of symptoms and dysfunction to
a better understanding of how and if exercises affect the onset and
progression of the knee OA process. Better rehabilitation programs for
patients with focal cartilage defects, patients with signiﬁcant predictors
for development of knee OA, needs to be undertaken. Themuscles of the
lower extremity, particular the quadriceps, have shown to play an
important role in the management of patients with knee OA.
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ROLE OF COMPLEMENT AND INFLAMMATION IN OSTEOARTHRITIS
W. Robinson. VA Palo Alto Hlth. Care System, Palo Alto, CA, USA
Purpose: Although low-grade inﬂammatory responses are observed in
OA, their contribution to its pathogenesis is unclear. We are investi-
gating the role for the complement system and inﬂammation in the
pathogenesis of OA.
Methods: Proteomic studies were performed on OA synovial ﬂuids and
membranes. Murine models of OA were used to further investigate the
role of the complement system and other inﬂammatory mediators.
Results: Through proteomic analyses of synovial ﬂuids and membranes
from individuals with osteoarthritis, we ﬁnd that expression and acti-
vation of complement and other inﬂammatory mediators in human
osteoarthritic joints. Using mice genetically deﬁcient in C5, C6, or
CD59a, we show that complement, and speciﬁcally the membrane
attack complex (MAC)-mediated arm of complement, is critical to the
development of OA. Immunoﬂuorescent staining demonstrated that
MAC co-localized with matrix metalloprotease (MMP)-13 and with
activated extracellular signal-regulated kinase (ERK) around chon-
drocytes in human osteoarthritic cartilage.
Conclusions: Our ﬁndings indicate that dysregulation of complement
and activation of inﬂammatory pathways in synovial joints plays
a critical role in the pathogenesis of osteoarthritis.
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SYNDECAN-4: ENVIRONMENTAL SENSOR AND MATRIX REGULATOR
M.R. Morgan. Univ. of Manchester, Manchester, United Kingdom
Cell migration and microenvironment remodeling are essential for
tissue morphogenesis, homeostasis and repair, and for the pathogenesis
of inﬂammatory, neoplastic and degenerative musculoskeletal diseases.
Adhesion contacts are integrin-mediated complexes that integrate the
extracellular environment with the contractile machinery of the cell.
Precise spatial and temporal coordination of adhesion complex
dynamics is essential to permit efﬁcient cell migration and to regulate
extracellular matrix remodelling.
Differential engagement of a5b1 and aVb3 integrins regulates the
balance between adhesion contact turnover and stabilisation. However,
the mechanisms that dynamically control heterodimer-speciﬁc delivery
of integrins to the cell surface, in order to coordinate adhesion
dynamics, are poorly understood. We have identiﬁed the membrane-
intercalated proteoglycan syndecan-4, which serves a key role in the
development of osteoarthritis, as the regulatory control point that
coordinates integrin recycling.
Abstracts / Osteoarthritis and Cartilage 21 (2013) S1–S8S6We have shown that the non-receptor tyrosine kinase Src phosphory-
lates syndecan-4 to suppress activation of the small GTPase Arf6.
Crucially, syndecan-4-mediated Arf6 activity differentially regulates
recycling of the a5b1 and aVb3 integrin heterodimers to themembrane,
to control adhesion complex dynamics. Thus, syndecan-4 phosphory-
lation functions as a molecular switch to target speciﬁc integrin het-
erodimers to the membrane and modulate FA stability and matrix
remodelling. We propose that maintenance of normal tissue architec-
ture and function requires the precise spatial and temporal regulation of
syndecan-4 phosphorylation, to coordinate integrin trafﬁcking,
dynamically regulate interaction with the matrix, and to control cell
migration and the integrity of the extracellular environment.
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FEMORAL SHAPE AND IMPINGEMENT
H. Weinans. UMC Utrecht, Utrecht, Netherlands
From a mechanical perspective congruency of the joint is important
for appropriate articulation with mechanical loading that is well
distributed over the joint surface. Whereas severe abnormal shapes
clearly create an articulation problem and can lead to OA, it is
currently recognized that subtle shape differences can be a risk factor
for OA as well. Bone shapes vary between persons and likely there are
good and bad shapes with respect to joint functioning. Variations of
bone shape among the population have been investigated ever since
the introduction of radiographic imaging. The idea that in hip OA
many cases of primary OA is actually secondary to a non-optimal
shape of the joint goes many years back. For example Perthes' disease,
slipped capital femoral epiphysis and congenital hip dysplasia clearly
pose a high risk for developing OA. Therefore mild subclinical forms of
these pathological conditions might also form a (smaller) risk factor of
OA. Many shape aspects have been identiﬁed that are associated with
OA such as: a decreased anteversion angle of the femoral neck,
retroversion of the acetabulum, a deep acetabular socket or a non-
spherical head shape. These are all well (pre)deﬁned geometry
aspects. However it is not straightforward to quantify shape variations
in general and new methods have recently been introduced that can
help to identify and ﬁnd subtle aspects of shape variation within
a given population. The importance of these variations in relation to
OA development or OA progression has only started to be uncovered
recently.
The most thorough method to determine shape variations from radio-
graphic images is using so-called statistical shape or appearance
models, where the latter also provides the density variation. In these
models a contour is created along landmark points of the bone that
together annotate the shape. For a given population all contours can
now be compared through scaling and rotation to obtain a best ﬁt.
Subsequently the contour coordinates are recombined with principal
component analysis to derive independent components (modes) that
represent the variation in shape within that population. Using this
methodology speciﬁc shape modes can be found that are strongly
associated with OA and even certain geometries of the hip were iden-
tiﬁed that correlate with OA characteristics dependent on the carrier
status of the DIO2 gene SNP.
A more direct approach is to use predeﬁned shape parameters that are
suspect of contributing to OA. One of the most well studied parame-
ters in this respect is sphericity of the femoral head. A non-spherical
head might create a diminished range of motion of the hip joint as
a consequence of femoral acetabular impingement. This problem has
been well described lately by Ganz and coworkers and often concerns
the formation of extra bone at the antero-lateral head neck junction;
a so-called Cam-type deformity. There is now general consensus that
this deformity is initiated during puberty, likely induced by mechan-
ical loading such as high impact sport activities and not evolves
with time in adults. However many clinical studies do show that
severe clinical problems related to Cam impingement become evident
at adult (but relatively young) age and there is a current trend to
operatively remove the Cam deformity in order to prevent OA later in
life.
The current work on shape analyses can provide imaging related (bio)
markers that might predict OA initiation and/or progression. These
shape related reasons of OA puts the deﬁnition of ‘idiopathic’ or primary
OA in a new context. Furthermore new tools to quantify joint shape can
help to elucidate more subtle risk factors and ﬁnd cause effect rela-
tionships related to genes that contribute to OA.I-19
HEDGEHOG SIGNALING IN OSTEOARTHRITIS
B. Alman. Hosp. for Sick Children, Toronto, ON, Canada
Purpose: Hedgehog signaling plays a critical role in chondrocytes
during development and as such could also play a role in articular
chondrocyte degeneration. This study will determine the role of
hedgehog signaling and in cartilage degeneration and osteoarthritis.
Methods: Human osteoarthritis samples were examined to deter-
mine if hedgehog signaling is dysregulated in osteoarthritis. Using
array analysis and chromatin immunoprecipitation, hedgehog target
genes were identiﬁed. Genetically modiﬁed mice in which hedgehog
transcriptional activation can be modulated and in which
target genes can be modiﬁed were used to determine how this
modulates spontaneous and traumatic onset articular cartilage
degeneration.
Results: Hedgehog signaling is activated in human and murine osteo-
arthritis. Inhibiting hedgehog signaling pharmacologically or geneti-
cally inhibits the development of osteoarthritis, while activating the
pathway worsens the severity of cartilage degeneration. Hedgehog
signaling regulated genes that modulate intracellular cholesterol. Mice
lacking the ability to degrade cholesterol in chondrocytes developed
worse cartilage degeneration and inhibiting cholesterol decreased the
severity of osteoarthritis.
Conclusions: Hedgehog signaling and its target genes regulate articular
cartilage degeneration. Pharmacologic inhibition of hedgehog signaling
or intracellular cholesterol could be used as a therapeutic approach to
prevent or treat cartilage degeneration in osteoarthritis.
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WE SHOULD TREAT PAIN!
M.C. Hochberg. Univ. of Maryland, Baltimore, MD, USA
Persons with structural changes of osteoarthritis (OA) become patients
when they present to health care providers with symptomatic
complaints; most often pain, aching or discomfort, but also stiffness.
These symptoms may be accompanied by signs on physical exami-
nation consistent with OA with or without local inﬂammation. This
presentation will focus on 1) the impact of symptoms of OA on activity
limitation, physical disability and reduced health-related quality of life
and 2) the effect of improvement in pain on reduction in activity
limitation and physical disability and improvement in health-related
quality of life.
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MOUSE MODELS OF JOINT DISORDERS
M.J. Hilton. Univ. of Rochester Med. Ctr., Rochester, NY, USA
Over the last decade, mice have become a valuable tool in the study of
joint disorders. The primary reasons for this include the high degree of
similarities that exist between human and mouse joint structures and
the genes/proteins involved in joint development and maintenance,
the genetic tractability of the mouse, and the develop of methods for
the surgical and chemical induction of joint cartilage degeneration.
The use of mice and the development of unique murine models of
joint disorders have provided enormous insight into the molecular
underpinnings of human cartilage related joint diseases. In particular,
the use of the Cre-LoxP technology to generate tissue and temporal
speciﬁc gene deletions/activations within joint tissues has identiﬁed
speciﬁc genes and pathways implicated in normal articular cartilage
development and joint maintenance and pathological joint degener-
ation. Similarly, the surgical destabilization of murine knee joints has
served as an important platform for studying the progression of
osteoarthritis (OA) and the genes involved in that process. During the
course of this workshop we will discuss several important murine
models of joint disorders, with a particular emphasis on 1) the utili-
zation of murine surgical models of knee joint destabilization to test a)
the involvement of speciﬁc genes in OA progression and b) the
effectiveness of potential disease modifying osteoarthritis drugs
(DMOADs), 2) the selection and utility of various Cre transgenic mice
for temporal and tissue speciﬁc gene deletions/activations in joint
tissues, and 3) the speciﬁc roles that various genetic pathways
(Wnt/Beta-catenin, TGFb, Ihh, and Notch) play in regulating anabolic
and catabolic factors that are important for normal articular cartilage
and joint maintenance.
